Aurinia Pharmaceuticals Inc. (AUPH)
USD 7.36
(-5.83%)
USD 7.36
(-5.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 175.51 Million USD | 30.95% |
| 2022 | 134.03 Million USD | 193.89% |
| 2021 | 45.6 Million USD | -9.0% |
| 2020 | 50.11 Million USD | 15660.38% |
| 2019 | 318 Thousand USD | -31.32% |
| 2018 | 463 Thousand USD | 10.24% |
| 2017 | 420 Thousand USD | 142.77% |
| 2016 | 173 Thousand USD | -26.38% |
| 2015 | 235 Thousand USD | -15.47% |
| 2014 | 278 Thousand USD | -70.69% |
| 2013 | 948.56 Thousand USD | -84.6% |
| 2012 | 6.15 Million USD | 563.9% |
| 2011 | 927.52 Thousand USD | -72.88% |
| 2010 | 3.42 Million USD | -15.59% |
| 2009 | 4.05 Million USD | 4.52% |
| 2008 | 3.87 Million USD | 66.05% |
| 2007 | 2.33 Million USD | -33.72% |
| 2006 | 3.52 Million USD | 199.06% |
| 2005 | 1.17 Million USD | -7.51% |
| 2004 | 1.27 Million USD | -83.38% |
| 2003 | 7.66 Million USD | -35.71% |
| 2002 | 11.91 Million USD | 124.97% |
| 2001 | 5.29 Million USD | 486.77% |
| 2000 | 902.77 Thousand USD | -33.53% |
| 1999 | 1.35 Million USD | 73.85% |
| 1998 | 781.25 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 50.3 Million USD | 11.55% |
| 2024 Q2 | 57.19 Million USD | 13.7% |
| 2023 Q2 | 41.49 Million USD | 20.59% |
| 2023 Q4 | 45.09 Million USD | -17.28% |
| 2023 Q3 | 54.51 Million USD | 31.38% |
| 2023 Q1 | 34.4 Million USD | 21.01% |
| 2023 FY | 175.51 Million USD | 30.95% |
| 2022 Q3 | 55.77 Million USD | 97.86% |
| 2022 Q2 | 28.19 Million USD | 30.36% |
| 2022 Q1 | 21.62 Million USD | -7.6% |
| 2022 FY | 134.03 Million USD | 193.89% |
| 2022 Q4 | 28.43 Million USD | -49.02% |
| 2021 Q1 | 914 Thousand USD | -98.17% |
| 2021 Q2 | 6.62 Million USD | 624.29% |
| 2021 FY | 45.6 Million USD | -9.0% |
| 2021 Q4 | 23.4 Million USD | 59.57% |
| 2021 Q3 | 14.66 Million USD | 121.56% |
| 2020 Q2 | 29 Thousand USD | -3.33% |
| 2020 Q3 | 29 Thousand USD | 0.0% |
| 2020 Q4 | 50.03 Million USD | 172417.24% |
| 2020 Q1 | 30 Thousand USD | 3.45% |
| 2020 FY | 50.11 Million USD | 15660.38% |
| 2019 Q3 | 230 Thousand USD | 693.1% |
| 2019 Q4 | 29 Thousand USD | -87.39% |
| 2019 Q2 | 29 Thousand USD | -3.33% |
| 2019 FY | 318 Thousand USD | -31.32% |
| 2019 Q1 | 30 Thousand USD | 3.45% |
| 2018 Q3 | 375 Thousand USD | 1193.1% |
| 2018 Q1 | 30 Thousand USD | -3.23% |
| 2018 FY | 463 Thousand USD | 10.24% |
| 2018 Q4 | 29 Thousand USD | -92.27% |
| 2018 Q2 | 29 Thousand USD | -3.33% |
| 2017 Q3 | 29 Thousand USD | -91.19% |
| 2017 FY | 420 Thousand USD | 142.77% |
| 2017 Q4 | 31 Thousand USD | 6.9% |
| 2017 Q1 | 31 Thousand USD | 3.33% |
| 2017 Q2 | 329 Thousand USD | 961.29% |
| 2016 Q2 | 55 Thousand USD | -3.51% |
| 2016 Q4 | 30 Thousand USD | -3.23% |
| 2016 FY | 173 Thousand USD | -26.38% |
| 2016 Q3 | 31 Thousand USD | -43.64% |
| 2016 Q1 | 57 Thousand USD | 0.0% |
| 2015 Q3 | 57 Thousand USD | -3.39% |
| 2015 FY | 235 Thousand USD | -15.47% |
| 2015 Q2 | 59 Thousand USD | -4.84% |
| 2015 Q1 | 62 Thousand USD | -8.82% |
| 2015 Q4 | 57 Thousand USD | 0.0% |
| 2014 Q4 | 68 Thousand USD | -5.56% |
| 2014 Q3 | 72 Thousand USD | 1.41% |
| 2014 Q2 | 71 Thousand USD | 5.97% |
| 2014 Q1 | 67 Thousand USD | -90.33% |
| 2014 FY | 278 Thousand USD | -70.69% |
| 2013 Q3 | 84.33 Thousand USD | 1.99% |
| 2013 Q1 | 87.47 Thousand USD | 1.47% |
| 2013 Q4 | 692.64 Thousand USD | 721.29% |
| 2013 FY | 948.56 Thousand USD | -84.6% |
| 2013 Q2 | 82.68 Thousand USD | -5.47% |
| 2012 FY | 6.15 Million USD | 563.9% |
| 2012 Q4 | 86.2 Thousand USD | -1.34% |
| 2012 Q3 | 87.37 Thousand USD | -1.25% |
| 2012 Q2 | 88.48 Thousand USD | -98.48% |
| 2012 Q1 | 5.81 Million USD | 4745.8% |
| 2011 Q1 | 137.87 Thousand USD | -53.7% |
| 2011 Q4 | 119.96 Thousand USD | -77.57% |
| 2011 Q3 | 534.83 Thousand USD | 250.0% |
| 2011 FY | 927.52 Thousand USD | -72.88% |
| 2011 Q2 | 152.81 Thousand USD | 10.83% |
| 2010 Q1 | 1.44 Million USD | -12.58% |
| 2010 FY | 3.42 Million USD | -15.59% |
| 2010 Q4 | 297.75 Thousand USD | 12.95% |
| 2010 Q3 | 263.61 Thousand USD | -81.35% |
| 2010 Q2 | 1.41 Million USD | -2.37% |
| 2009 Q1 | 647.02 Thousand USD | 592.4% |
| 2009 Q4 | 1.65 Million USD | 72.55% |
| 2009 FY | 4.05 Million USD | 4.52% |
| 2009 Q2 | 618.45 Thousand USD | -4.42% |
| 2009 Q3 | 959.86 Thousand USD | 55.2% |
| 2008 FY | 3.87 Million USD | 66.05% |
| 2008 Q4 | 93.44 Thousand USD | -96.54% |
| 2008 Q3 | 2.7 Million USD | 386.86% |
| 2008 Q2 | 555.11 Thousand USD | -1.32% |
| 2008 Q1 | 562.51 Thousand USD | -8.72% |
| 2007 Q1 | 605.92 Thousand USD | -5.03% |
| 2007 Q4 | 616.27 Thousand USD | 11.24% |
| 2007 Q3 | 553.98 Thousand USD | 29.04% |
| 2007 Q2 | 429.3 Thousand USD | -29.15% |
| 2007 FY | 2.33 Million USD | -33.72% |
| 2006 Q3 | 519.43 Thousand USD | -44.56% |
| 2006 Q2 | 936.99 Thousand USD | -31.56% |
| 2006 Q1 | 1.36 Million USD | 221.08% |
| 2006 Q4 | 637.99 Thousand USD | 22.83% |
| 2006 FY | 3.52 Million USD | 199.06% |
| 2005 Q3 | 1.76 Million USD | 764.01% |
| 2005 FY | 1.17 Million USD | -7.51% |
| 2005 Q2 | 204.07 Thousand USD | -35.71% |
| 2005 Q1 | 317.43 Thousand USD | 24.25% |
| 2005 Q4 | -1.13 Million USD | -164.12% |
| 2004 Q3 | 262.45 Thousand USD | 2.91% |
| 2004 FY | 1.27 Million USD | -83.38% |
| 2004 Q1 | 467.5 Thousand USD | -24.06% |
| 2004 Q4 | 255.47 Thousand USD | -2.66% |
| 2004 Q2 | 255.03 Thousand USD | -45.45% |
| 2003 Q3 | 306.91 Thousand USD | -95.3% |
| 2003 Q1 | 215.97 Thousand USD | -28.12% |
| 2003 FY | 7.66 Million USD | -35.71% |
| 2003 Q4 | 615.63 Thousand USD | 100.59% |
| 2003 Q2 | 6.52 Million USD | 2923.27% |
| 2002 Q1 | 2.2 Million USD | 0.0% |
| 2002 FY | 11.91 Million USD | 124.97% |
| 2002 Q4 | 300.44 Thousand USD | -92.83% |
| 2002 Q3 | 4.18 Million USD | -23.23% |
| 2002 Q2 | 5.45 Million USD | 147.73% |
| 2001 Q2 | 522.26 Thousand USD | 16.64% |
| 2001 Q1 | 447.75 Thousand USD | 49.66% |
| 2001 FY | 5.29 Million USD | 486.77% |
| 2001 Q3 | 522.69 Thousand USD | 0.08% |
| 2000 Q4 | 299.18 Thousand USD | 20.07% |
| 2000 Q2 | 66.74 Thousand USD | -75.79% |
| 2000 FY | 902.77 Thousand USD | -33.53% |
| 2000 Q1 | 275.66 Thousand USD | -43.56% |
| 2000 Q3 | 249.17 Thousand USD | 273.35% |
| 1999 Q4 | 488.37 Thousand USD | 143.3% |
| 1999 FY | 1.35 Million USD | 73.85% |
| 1999 Q1 | 397.74 Thousand USD | 0.0% |
| 1999 Q3 | 200.72 Thousand USD | -26.01% |
| 1999 Q2 | 271.28 Thousand USD | -31.8% |
| 1998 FY | 781.25 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -361.573% |
| Alkermes plc | 1.66 Billion USD | 89.449% |
| Agenus Inc. | 156.31 Million USD | -12.282% |
| Aptorum Group Limited | 431.37 Thousand USD | -40586.59% |
| Ardelyx, Inc. | 124.45 Million USD | -41.024% |
| Dyadic International, Inc. | 2.89 Million USD | -5954.665% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -454.684% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -67275.432% |
| Novavax, Inc. | 983.7 Million USD | 82.158% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -2071.384% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -821.376% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -1666.435% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -21784.414% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -7.076% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -2033.637% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -745.601% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 90.4% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 27.093% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -41294.575% |
| Bicycle Therapeutics plc | 26.97 Million USD | -550.626% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -12618.333% |
| ChromaDex Corporation | 83.57 Million USD | -110.019% |
| Chimerix, Inc. | 324 Thousand USD | -54070.679% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -409.073% |
| CRISPR Therapeutics AG | 371.2 Million USD | 52.718% |
| Precision BioSciences, Inc. | 48.72 Million USD | -260.197% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -176.255% |
| Fortress Biotech, Inc. | 84.51 Million USD | -107.676% |
| Fortress Biotech, Inc. | 84.51 Million USD | -107.676% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -771.941% |
| ImmuCell Corporation | 17.47 Million USD | -904.558% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -650.537% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 95.251% |
| Innoviva, Inc. | 310.46 Million USD | 43.467% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -1698.105% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -116133.775% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -33.659% |
| ContextLogic Inc. | 287 Million USD | 38.846% |
| MiMedx Group, Inc. | 321.47 Million USD | 45.404% |
| MEI Pharma, Inc. | 65.29 Million USD | -168.792% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -300101.83% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -22258.344% |
| Opthea Limited | 261.85 Thousand USD | -66925.766% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -2719.486% |
| Pharming Group N.V. | 245.31 Million USD | 28.454% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -25635.044% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -309.981% |
| PureTech Health plc | 3.33 Million USD | -5170.661% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -50.163% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -1735.91% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | 0.408% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -11194.273% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -6753.299% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -1899.009% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -3510160.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -36.043% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -16395.583% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -54.903% |
| Seer, Inc. | 15.18 Million USD | -1056.06% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -3325.312% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -620.674% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -1755030.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -9650.722% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | 9.819% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | 55.924% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -6259.167% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -179.306% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -1357.144% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -20810.361% |
| Century Therapeutics, Inc. | 2.23 Million USD | -7752.931% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -733.831% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -73.408% |
| Autolus Therapeutics plc | 1.69 Million USD | -10236.455% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -281.401% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -258007.353% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -3.076% |
| GRI Bio, Inc. | 21.76 Million USD | -706.326% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6809.999% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -8140.047% |
| INmune Bio, Inc. | 155 Thousand USD | -113134.194% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -38.151% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -7738.933% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -17451.3% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -1947.276% |
| Coherus BioSciences, Inc. | 257.24 Million USD | 31.772% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -4914.657% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -11008.418% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -2159.436% |
| Histogen Inc. | 3.76 Million USD | -4556.752% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -29993.222% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -160921.101% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -44708.588% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -418.058% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -2461.112% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -11.262% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -120279.287% |
| Apollomics, Inc. | 821 Thousand USD | -21277.954% |
| Amarin Corporation plc | 306.91 Million USD | 42.813% |
| Mesoblast Limited | 5.9 Million USD | -2873.789% |
| Turnstone Biologics Corp. | 19.3 Million USD | -809.111% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -123.322% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 90.41% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -127.977% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | 55.745% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -13086.551% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -25.446% |
| Insmed Incorporated | 305.2 Million USD | 42.494% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -839.275% |
| OmniAb, Inc. | 34.16 Million USD | -413.737% |
| Alector, Inc. | 97.06 Million USD | -80.826% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -38.938% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -170300.971% |
| Zai Lab Limited | 266.71 Million USD | 34.196% |
| Revance Therapeutics, Inc. | 234.04 Million USD | 25.007% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -134910.0% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -905.978% |
| Veracyte, Inc. | 361.05 Million USD | 51.388% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -3717.384% |
| FibroGen, Inc. | 147.75 Million USD | -18.789% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -118646.321% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 95.422% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -41688.81% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | 53.908% |
| TG Therapeutics, Inc. | 233.66 Million USD | 24.886% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 94.355% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -11165.276% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -413.872% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -106.927% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -205.644% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | 59.582% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -292.155% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | 47.041% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -317973.577% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -574.946% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -1950044.444% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -5200.693% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 98.662% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -143631.165% |
| Pluri Inc. | 326 Thousand USD | -53738.344% |
| Prothena Corporation plc | 91.37 Million USD | -92.09% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -191.158% |
| Celularity Inc. | 22.77 Million USD | -670.774% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -3096.958% |
| MeiraGTx Holdings plc | 14.01 Million USD | -1152.144% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | 29.634% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -174.647% |
| Blueprint Medicines Corporation | 249.38 Million USD | 29.62% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -466.372% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -2304.947% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -383.84% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -3413.314% |
| Cytokinetics, Incorporated | 7.53 Million USD | -2230.85% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -8316.622% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -40.641% |
| Evogene Ltd. | 5.64 Million USD | -3011.933% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -1656.359% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -1786.628% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -3556.521% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -380.502% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -55795.86% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -8675.65% |
| MediciNova, Inc. | 1 Million USD | -17451.3% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -7072.579% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -1028396.924% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | 35.139% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | 81.285% |
| Mereo BioPharma Group plc | 10 Million USD | -1655.13% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -2969.482% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -746.948% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | 35.057% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -6157.148% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | 63.615% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -184650.526% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -3588.798% |
| Kezar Life Sciences, Inc. | 7 Million USD | -2407.329% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -737.052% |
| aTyr Pharma, Inc. | 353 Thousand USD | -49620.397% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -1030.227% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -55795.86% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -1455352.359% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | 78.835% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -77489.21% |
| UroGen Pharma Ltd. | 82.71 Million USD | -112.195% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -14.169% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -634666.727% |
| Orgenesis Inc. | 530 Thousand USD | -33015.66% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -4.262% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -69115.965% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | 8.891% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -77489.21% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -1028396.924% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -11577.512% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -3272.166% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -1501.542% |
| scPharmaceuticals Inc. | 13.59 Million USD | -1191.201% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -1651.102% |
| Daré Bioscience, Inc. | 2.8 Million USD | -6150.719% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -95287.5% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 92.862% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -1415.656% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -192.522% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -495.02% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 92.745% |
| DBV Technologies S.A. | 15.72 Million USD | -1015.927% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 97.437% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2092.268% |
| Molecular Templates, Inc. | 57.3 Million USD | -206.273% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -20.845% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -1639.647% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -2449.949% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -198.751% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -27103.895% |
| Adagene Inc. | 18.11 Million USD | -869.07% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -16121.165% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | 39.257% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | 29.797% |
| SciSparc Ltd. | 2.87 Million USD | -5996.318% |
| Vericel Corporation | 197.51 Million USD | 11.14% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -2872.781% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -194.455% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -587.047% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -81.437% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -74.836% |
| ADMA Biologics, Inc. | 258.21 Million USD | 32.028% |
| Clene Inc. | 654 Thousand USD | -26736.85% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -597.087% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -293.748% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -251.026% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -163930.841% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -103.659% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -239960.455% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -200.315% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -1392.711% |
| Trevena, Inc. | 3.12 Million USD | -5516.416% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | 75.839% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -2691.237% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -2128.454% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -28117.524% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -3125.156% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -150.222% |
| Celularity Inc. | 22.77 Million USD | -670.774% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -4273.611% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -112106.957% |
| Cibus, Inc. | 1.81 Million USD | -9559.494% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -4775.361% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -2350.272% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -9022.297% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | 77.717% |
| Eyenovia, Inc. | 3787.00 USD | -4634518.431% |
| Puma Biotechnology, Inc. | 235.63 Million USD | 25.516% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -59.096% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -35865.779% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -121.596% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -19292.652% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -73956.118% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -2492.894% |
| Royalty Pharma plc | 2.35 Billion USD | 92.546% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -23816.056% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -376.226% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -103142.941% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -14477.492% |
| Notable Labs, Ltd. | 310 Thousand USD | -56517.097% |
| Liquidia Corporation | 17.48 Million USD | -903.62% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -16121.165% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -867.494% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -9326.047% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -10148.366% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 92.459% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -243323.206% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -3588.798% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -584943.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -1007.827% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -171.259% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -41100.235% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | 56.051% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -424.561% |
| Peak Bio, Inc. | 367.87 Thousand USD | -47609.696% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -539.136% |
| Benitec Biopharma Inc. | 216 Thousand USD | -81156.019% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -19709.594% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 85.688% |
| Immunome, Inc. | 14.01 Million USD | -1152.055% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -10492.215% |
| CervoMed Inc. | 7.14 Million USD | -2356.489% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -3472.42% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -6110.651% |
| Moolec Science SA | 905.04 Thousand USD | -19292.652% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -20995.059% |
| AnaptysBio, Inc. | 17.15 Million USD | -922.982% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -7034.533% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -7867.0% |
| Lumos Pharma, Inc. | 2.05 Million USD | -8457.435% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -330.969% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -8316.622% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -85935.784% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -146160.833% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -70105.2% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | 53.532% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | 5.828% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -338.783% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -14661.396% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -1035.933% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -30691.754% |
| HCW Biologics Inc. | 2.84 Million USD | -6076.134% |
| XOMA Corporation | 4.75 Million USD | -3588.798% |
| Nektar Therapeutics | 90.12 Million USD | -94.75% |
| Arvinas, Inc. | 78.5 Million USD | -123.583% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -299.374% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -5572.689% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -26736.85% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -9923.587% |
| Synlogic, Inc. | 3.37 Million USD | -5106.556% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -47609.696% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -780.073% |
| Krystal Biotech, Inc. | 50.69 Million USD | -246.186% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -20.187% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -3122.196% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -38936.113% |
| MannKind Corporation | 198.96 Million USD | 11.786% |
| Ikena Oncology, Inc. | 9.16 Million USD | -1816.081% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -54.705% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | 38.447% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -4387725.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -249.941% |
| REGENXBIO Inc. | 90.24 Million USD | -94.491% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -7768.703% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -2278.547% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -23146.755% |
| Longeveron Inc. | 709 Thousand USD | -24655.007% |
| Repare Therapeutics Inc. | 51.13 Million USD | -243.248% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 85.884% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -1415.656% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -83477.619% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 98.222% |
| Denali Therapeutics Inc. | 330.53 Million USD | 46.9% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -976.968% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -6393.267% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -126.679% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -115043.344% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -1076.439% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -25901.926% |
| OmniAb, Inc. | 34.16 Million USD | -413.737% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -725.866% |
| Lipocine Inc. | -2.85 Million USD | 6256.584% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -7738.933% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -112.715% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -103.011% |
| Ocugen, Inc. | 6.03 Million USD | -2807.77% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -15082.785% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -386.401% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -2824.142% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -27622.705% |
| Dominari Holdings Inc. | 2.03 Million USD | -8507.798% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | 84.857% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -554.338% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | 69.844% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -1293.513% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -36695.178% |
| Iterum Therapeutics plc | - USD | -Infinity% |